Wegovy Weight Loss Pill Shows 'Substantial' Results in UK
A major UK trial reveals the new semaglutide pill, a potential game-changer in obesity treatment, leads to significant weight loss, offering a powerful alternative to injections.
Category : Search result: Novo Nordisk
Novo Nordisk's £90m UK Expansion for Ozempic Production
Danish pharmaceutical giant Novo Nordisk announces major £90 million expansion at its Gatwick facility to meet soaring global demand for its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, creating new high-skilled jobs.
Wegovy Jab Sends Novo Nordisk Shares Soaring Past £400bn
Danish pharmaceutical giant Novo Nordisk's market value skyrockets past £400bn, briefly eclipsing the entire Danish economy, on the back of soaring demand for its blockbuster weight-loss drug, Wegovy.
Germany seizes illegal Wegovy shipment in Frankfurt
German authorities have confiscated thousands of doses of the in-demand weight-loss medication Wegovy from a Frankfurt wholesaler, citing illegal parallel imports from outside the EU and improper storage conditions.
Trump's New EU Tariffs Spark Market Sell-Off
Global markets reel as former President Donald Trump announces sweeping new tariffs on the EU, targeting key industries from cars to pharmaceuticals. The move sends the pound and euro tumbling and casts a shadow over Novo Nordisk's major UK investment pla
Novo Nordisk cuts 9,000 jobs amid Ozempic competition
Danish pharmaceutical giant Novo Nordisk announces major restructuring, cutting 9,000 jobs globally. The move comes as competition intensifies in the lucrative weight-loss and diabetes drug market, challenging its blockbuster medications Ozempic and Wegov
Novo Nordisk reduces Ozempic and Wegovy prices
Novo Nordisk has announced significant price cuts for its popular weight-loss and diabetes drugs, Ozempic and Wegovy, making them more accessible to patients across the UK.
Mounjaro and Ozempic prices surge amid high demand
The cost of diabetes and weight-loss drugs Mounjaro and Ozempic has surged, sparking concerns over affordability and market competition. Experts weigh in on the implications.
Novo Nordisk diabetes drug sales slow sharply
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.
Wegovy sales boost Novo Nordisk shares
Novo Nordisk's blockbuster weight-loss drug Wegovy drives record sales, boosting shares and intensifying competition with Eli Lilly.
Wegovy weight-loss jab in high demand amid US obesity crisis
The US obesity epidemic has led to soaring demand for Wegovy, a weight-loss injection containing semaglutide. Experts warn of supply shortages as prescriptions surge.
Page 1 of 1